Results 71 to 80 of about 796 (164)

Efficacy and Safety of Adjunctive Cenobamate in Chinese Participants with Focal Seizure. [PDF]

Adv Ther
Yu P, Wu X, Cui L, Pan S, Han Y, Xu H, Zhu S, Wang X, Huang H, Wang T, Liao W, Zhang M, Tang L, Sun H, Qin B, Hu Z, Feng J, Chen Y, Zhang M, Li Q, Han X, Xiao B, Chen H, Li L, Liang Y, Ye H, Liu Y, Hong Z, Zhou D.   +28 more
europepmc   +1 more source

Long-Term Impact of Cenobamate on Cognition, Adaptive Behavior, and Quality of Life in Patients with Tuberous Sclerosis Complex. [PDF]

Neurol Ther
Operto FF, Pastorino GMG, Charlier B, Izzo V, Martino I, Moavero R, Mungo N, Olivieri M, Sammara I, Gambardella A.   +9 more
europepmc   +1 more source

Early response rates with adjunctive cenobamate in uncontrolled focal seizures: Prospective analysis of a randomized, double-blind, placebo-controlled study in a multinational Asian population. [PDF]

Epilepsia
Kawai K, Choe E, Ferrari L, Heo K, Hong SB, Huang H, Iida K, Jeon YH, Jung J, Kamin M, Kim JH, Kim MW, Lee SK, Pan S, Park J, Pradhan P, Rosenfeld WE, Xu H, Yamamoto T, Misra SN.   +19 more
europepmc   +1 more source

Freedon study: Real-life outcomes of cenobamate in different lines of treatment. [PDF]

Epilepsia
Villanueva V, Serratosa JM, Fernández-Cabrera A, Toledo M, González-Giráldez B, Estevez JC, Rodríguez Uranga JJ, Machio Castelló M, Castro-Vilanova MD, Poza JJ, Rodríguez-Osorio X, Hampel KG, Fonseca E, López-González FJ, Garcés M, Abraira L, Ciurans J, Campos-Fernández D, Santamarina E, Sanchez-Caro JM, Iacampo L, Renau J, García-Quesada MÁ, Anciones C, Chamorro MI, Maestro I, Cabezudo P, Calle R, Macarron J, Cabezas B, Carrasco M, López M, Marín M, Querol R, Baena B, García-Morales V, López-Maza S, Juiz Á, Mercedes-Alvarez B, Amarante C, Del Villar A, Castillo A, Rubio-Roy M, Martinez-Poles J, Gómez-Ibáñez A, Parejo-Carbonell B, Martínez Garcia A, Carrera I, Iriarte P, Romero-Aguilera F, Pharmacological Therapy Working group of the Spanish Epilepsy Society and Freedon Group.   +50 more
europepmc   +1 more source

Characteristics, therapeutic pathway and the economic burden of patients with drug-resistant epilepsy: A real-world analysis following the introduction of cenobamate in Italy. [PDF]

Epilepsia
Perrone V, Veronesi C, Cappuccilli M, Andretta M, Bacca M, Barbieri A, Bartolini F, Brega A, Cillo MR, Colasuonno F, Dell'Orco S, Ferrante F, Grego S, Lavalle A, Mancini D, Pastorello M, Pagliaro R, Procacci C, Scandolara C, Schiavone P, Ubertazzo L, Valpondi P, Vercellone A, Zucchi A, Ciappetta M, Lucatelli D, Cinti Luciani A, Degli Esposti L.   +27 more
europepmc   +1 more source

A New Antiseizure Medication: Cenobamate

Epilia: Epilepsy and Community, 2023
openaire   +1 more source

Long-term Impact of Cenobamate on Cognition in Patients with Drug-Resistant Focal Epilepsy: Outcomes from an Exploratory Real-World Study. [PDF]

Neurol Ther
Ramirez-Garcia T, Cabezudo-Garcia P, Garcia-Martin G, Lopez-Moreno Y, Sanchez-Guijo A, De La Parra J, Serrano-Castro PJ.   +6 more
europepmc   +1 more source

A randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of adjunctive cenobamate in Asian patients with focal seizures. [PDF]

Epilepsia
Lee SK, Yu P, Choe E, Ferrari L, Heo K, Hong SB, Hong Z, Iida K, Jeon YH, Jung J, Kamin M, Kawai K, Kim JH, Kim MW, Liu X, Park J, Rosenfeld WE, Yamamoto T, Zhou D, Zhu S, Misra SN.   +20 more
europepmc   +1 more source

The Cardiac Sodium Channel Safety Profile of Cenobamate at Therapeutic Concentrations: In Vitro Analyses. [PDF]

Clin Transl Sci
Crumb WJ, Melnick SM, Glenn KJ.
europepmc   +1 more source

Academia, industry and the slow adoption of new treatments. [PDF]

Brain
Klein P, Pong A, Koepp M, Löscher W, Sander JW, Faught E.   +5 more
europepmc   +1 more source